Europe Immunology Drugs Market Report 2017

DUBLIN, Jan. 31, 2018 /PRNewswire/ --

The "Europe Market Report Suite for Immunology Drugs 2017 - MedSuite" report has been added to ResearchAndMarkets.com's offering.

Besides the typical market data found above you will be able to discover how these diseases have been trending over time, their epidemiology, drivers and limiters of these markets, Porter's Five Forces analysis, clinical trials, a pipeline of products coming out soon, mergers and acquisitions, company profiles and SWOT analyses.

Key Topics Covered:

Report Guidance

Market Definition

Research Methodology

Executive Summary

Disease Overview
Rheumatoid Arthritis
Crohn's Disease
Ankylosing Spondylitis
Psoriasis
Ulcerative Colitis

Product Assessment
Clinical Trials Overview
Pipeline Analysis
Promising new drugs for Ankylosing Spondylitis in the pipeline
Promising new drugs for Crohn's Disease in the pipeline
Promising new drugs for Psoriasis in the pipeline
Promising new drugs for Rheumatoid Arthritis in the pipeline
Key Marketed Products Portfoilo
Orencia (abatacept)
Humira (adalimumab)
Cimzia (certolizumab)
Enbrel (etanercept)
Benepali (etanercept)
Simponi (golimumab)
Remicade (infliximab) + Remsima/Inflectra (infliximab)
Inflectra (infliximab)
Flixabi (infliximab)
Rituxan (rituximab)
Actemra/RoActemra (toclizumab)
XELJANZ (tofacitnib)
Kineret (anakinra)
Stelara (ustekinumab)
Entyvio (vedolizumab)
Tysabri (natalizumab)
Cosentyx (secukinumab)
Taltz (ixekizumab)

Drug Cost Analysis

Europe Immunology Market Overview
Introduction
Currency Exchange Rate

Europe Immunology Market - By Diseases
Market Overview
Rheumatoid Arthritis
Crohn's Disease
Ankylosing Spondylitis
Psoriasis
Ulcerative Colitis

Europe Immunology Market - By Treatments
Market Overview
Biologics (Biologic DMARDS)
Non-biologics (corticosteroids, NSAIDs, tDMARDS & other non-biologic)

Europe Immunology Biologics Segment Analysis - By Drugs
Rheumatoid Arthritis Drugs
Crohn's Disease Drugs
Ankylosing Spondylitis Drugs
Psoriasis Drugs
Ulcerative Colitis Drugs

Europe Immunology Biologics Segment Analysis - By Mechanism Of Action (MOA)
TNF
JFK
Others

Country Profiles
United Kingdom
France
Germany
Italy
Spain
Rest of Europe

Competitive Landscape
Mergers & Acquisitions
Collaborations & Agreements
Market Shares & Competitive Analysis - by key players

Company Profiles

• AbbVie Inc.
• AstraZeneca Plc
• F. Hoffmann-La Roche Ltd
• Johnson & Johnson
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Takeda Pharmaceuticals
• UCB S.A.

For more information about this report visit https://www.researchandmarkets.com/research/33qhnh/europe_immunology?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716